Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification

BACKGROUND: Patient-derived xenograft (PDX) models are important tools in precision medicine and for the development of targeted therapies to treat cancer patients. This study aimed to evaluate our precision medicine strategy that integrates genomic profiling and preclinical drug-screening platforms...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Doo-Yi, Jung, Kyungsoo, Song, Ji-Young, Kim, Seokhwi, Shin, Sang, Kwon, Yong-Jun, Oh, Ensel, Park, Woong-Yang, Song, Sang Yong, Choi, Yoon-La
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557466/
https://www.ncbi.nlm.nih.gov/pubmed/28806950
http://dx.doi.org/10.1186/s12885-017-3525-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557466/
https://www.ncbi.nlm.nih.gov/pubmed/28806950
http://dx.doi.org/10.1186/s12885-017-3525-9

Ejemplares similares